Instrument Inactif

Autres langues Zomedica Corp. Toronto S.E.

Actions

ZOM

CA98980M1095

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zomedica Announces Presentation of Compelling TRUFORMA Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference	07/06
Zomedica Completes Expansion of Manufacturing, Distribution Facilities in Roswell, Georgia	04/06
Zomedica Enhances TRUFORMA Platform with Launch of Advanced Canine Cortisol Assay	30/05
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA Platform	16/05
Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform	15/05
Earnings Flash (ZOM) ZOMEDICA Posts Q1 Revenue $6.3M	09/05
Zomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Zomedica Corp. Provides Revenue Guidance for Full Year 2024	09/05
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA Diagnostic Platform	03/05
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET	01/05
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024	10/04
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Zomedica Seeks Acquisitions	01/04
Earnings Flash (ZOM) ZOMEDICA Posts Q4 Revenue $7.3M	01/04
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024	01/04
Zomedica Announces Publication of Research Concluding TRUFORMA Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay Platform	15/03
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform	14/03
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences	13/03
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs	08/03
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024	06/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zomedica Corp. Toronto S.E.

Actions

ZOM

CA98980M1095

Autres langues

Filtres